Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
    • Education
  • Online Sections
    • Neurology Video Journal Club
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
    • Education
  • Online Sections
    • Neurology Video Journal Club
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in
  • Log out

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
  • Log out
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

Share

October 08, 2002; 59 (7) Brief Communications

The overlap of amyotrophic lateral sclerosis and frontotemporal dementia

Catherine Lomen-Hoerth, Thomas Anderson, Bruce Miller
First published October 8, 2002, DOI: https://doi.org/10.1212/WNL.59.7.1077
Catherine Lomen-Hoerth
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Anderson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bruce Miller
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Citation
The overlap of amyotrophic lateral sclerosis and frontotemporal dementia
Catherine Lomen-Hoerth, Thomas Anderson, Bruce Miller
Neurology Oct 2002, 59 (7) 1077-1079; DOI: 10.1212/WNL.59.7.1077

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
1986

Share

  • Article
  • Figures & Data
  • Info & Disclosures
Loading

Abstract

Patients with frontotemporal dementia (FTD) with no known diagnosis of ALS or family history of ALS were clinically and electrophysiologically assessed for the presence of ALS. Of 36 patients studied, five met criteria for a definite diagnosis of ALS and two had EMG findings suggestive of denervation in one limb. An additional five patients had prominent fasciculations and six other patients had trouble swallowing but all had normal results on EMG studies. One of the patients with fasciculations and a normal EMG study progressed to definite ALS over the course of 1 year.

Frontotemporal dementia (FTD) is a progressive dementing condition characterized by selective degeneration of the frontal and anterior temporal lobes, whereas ALS is a motor neuron disease with progressive loss of upper and lower motor neurons. Because these diseases attack different parts of the brain, the specialists caring for patients with the two conditions have vastly different areas of expertise and interests. However, recent reports suggest that the two disorders often develop together in the same patients. The frequency of this association remains unknown and the molecular mechanisms underlying the co-occurrence of FTD and ALS remain poorly understood.

A relationship among dementia, parkinsonism, and ALS was first noted after World War II in Guam among native Chamorros and was called the ALS-parkinsonism dementia complex of Guam1; more recently, an association between familial FTD and tau mutations on chromosome 17 has been described.2 In addition to familial associations between ALS and FTD, sporadic cases of FTD and ALS also seem to be common,3 although the prevalence and etiology for this co-association remains understudied. In some instances FTD precedes ALS by many years; in other instances, the ALS precedes the FTD.4 The incidence of FTD in patients with bulbar onset ALS has been reported as high as 48%.5 A systematic study of the co-association between FTD and ALS is lacking but needed. This co-association has practical importance and ALS coexisting with FTD significantly impacts the survival of these patients.

We describe a cross-sectional study on the co-association of FTD and ALS in an FTD population. Both clinical and electrophysiologic techniques were employed to help determine a diagnosis.

Methods.

Thirty-six consecutive patients with a clinical diagnosis of FTD were referred to clinicians with expertise in ALS (C.L.-H., T.A.) from the University of California, San Francisco (UCSF) and University of California, Los Angeles (UCLA) memory disorders centers. The patients were originally referred from community neurologists from a wide geographic area, including much of California and neighboring states. These patients had no known diagnosis of ALS or family history of ALS or FTD, and there was no preselection of patients with ALS symptoms. Patients with FTD were diagnosed based on clinical and neuropsychological testing and neuroimaging features and all would meet current Neary research criteria for FTD.6 All patients underwent a detailed neuromuscular examination and EMG studies after giving written informed consent for these studies. This study was approved by UCSF and Harbor/UCLA Research Education Institute Institutional Review Boards. The long-term goal of this study was to identify the frequency of ALS in FTD in two tertiary-care dementia centers with a special interest in FTD.

Results.

The results are summarized in the table. Five patients met criteria for the diagnosis of definite ALS based on the World Federation of Neurology criteria.7 All of these patients had severe FTD prior to developing symptoms of ALS. Five patients had fasciculations, but no abnormalities by EMG studies. Benign fasciculations are common, and studies suggest that the presence of fasciculations in the setting of a normal EMG carries a benign prognosis. However, most of these patients did not develop fasciculations until the development of FTD, so they may be more at risk than the general population. Finally, two patients had evidence of neurogenic change in one limb, but did not have other changes to document a diagnosis of ALS. It is difficult to determine whether these changes were related to the start of a motor neuron disease or due to focal injury in the past.

View this table:
  • View inline
  • View popup

Table 1Clinical characteristics of 36 patients with sporadic FTD

Six additional patients also had trouble with swallowing. It is difficult to determine whether the swallowing difficulty is from upper or lower motor neuron causes without laryngeal EMG studies. The patients with swallowing difficulty were not at any greater risk to have fasciculations or denervation in peripheral muscles than the other patients with FTD studied, but longitudinal follow-up will be important.

Thus, among 36 patients with FTD, we found 14% with definite ALS and an additional 36% with possible ALS. Re-evaluation of one of the five patients with fasciculations after 1 year identified development of definite ALS over the interval, bringing the total number of patients with ALS and FTD to six. This patient had FTD symptoms for 2 years prior to the development of fasciculations, and when first evaluated by EMG, the fasciculations had been present for only 6 weeks. Longitudinal studies will be necessary to determine whether others develop definite ALS, including the 13 other patients with possible ALS as well as the 18 patients with no earlier indication of motor neuron disease.

Discussion.

This study confirms that neuromuscular specialists will find ALS in many patients with FTD. In a previous study based on a chart review of our patient population with FTD, we reported that 15% of all cases either developed ALS or had a first-degree relative with ALS.8 In this prospective study we found that 14% of patients with FTD carried a diagnosis of definite ALS, whereas another 36% had features of this condition. Longitudinal follow-up is in progress that will include neuropathologic confirmation of diagnosis.

The incidence of ALS in familial and sporadic FTD or FTD in ALS has not been extensively studied. A recent review of 151 patients with ALS showed increased risk of PD and dementia in relatives based on clinical history.9 The risk of dementia was significantly higher in relatives of patients with ALS than controls (RR 1.9) and was similar for relatives of patients with sporadic and familial ALS. Similarly, the risk of PD was higher in relatives of patients with familial ALS (RR 5.6) than relatives of patients with sporadic ALS (RR 1.8). However, these patients with ALS did not have neuropsychological testing to determine whether they had any evidence of dementia. ALS is rarely seen in association with AD and we suspect that this association probably reflects the high incidence of FTD with ALS. Similarly, there is often temporal lobe degeneration and cortical ubiquitinated inclusions in ALS with or without dementia.10

For a variety of reasons, all of these earlier studies including our own probably underestimate the association between FTD and ALS. Patients with FTD and ALS tend to present first to an ALS center rather than to a memory disorders center. This is supported by our own work showing a 31% incidence of FTD symptoms in 100 patients with ALS presenting to the ALS Center at UCSF. Multidisciplinary studies that include cognitive and motor evaluations in these populations are rare. We used a cohort of convenience and not a population-based study, which may not reflect the prevalence of a disease in the general community. However, because the study speaks only to the incidence of ALS in FTD and not other dementias, it is appropriate to generalize the data to the FTD population as a whole.

Dementia is difficult to study in patients with ALS because the motor problems interfere with cognitive testing and ALS is difficult to evaluate in FTD because patients are often uncooperative for motor studies. Because patients need to pass a certain threshold before ALS can be diagnosed clinically, a single evaluation is likely to miss many patients who are in the process of losing motor neurons. Neuropathologic evaluations are needed that carefully assess both frontotemporal and motor neurons, yet such studies have not been performed. Ultimately, a better understanding of both conditions can be achieved by multidisciplinary evaluations of patients with both conditions.

  • Received March 22, 2002.
  • Accepted June 20, 2002.

References

  1. ↵
    McGeer PL, Schwab C, McGeer EG, et al. Familial nature and continuing morbidity of the amyotrophic lateral sclerosis–parkinsonism dementia complex of Guam. Neurology . 1997; 49: 400–409.
    OpenUrlAbstract/FREE Full Text
  2. ↵
    Foster NL, Wilhelmsen K, Sima AAF, et al. Frontotemporal dementia and parkinsonism linked to chromosome 17: a consensus conference. Ann Neurol . 1997; 41: 706–715.
    OpenUrlCrossRefPubMed
  3. ↵
    Neary D, Snowden JS, Mann DMA. Cognitive change in motor neurone disease/amyotrophic lateral sclerosis (MND/ALS). J Neurol Sci . 2000; 180: 15–20.
    OpenUrlCrossRefPubMed
  4. ↵
    Caselli RJ, Windeband AJ, Petersen RC, et al. Rapidly progressive aphasic dementia and motor neuron disease. Ann Neurol . 1993; 33: 200–207.
    OpenUrlCrossRefPubMed
  5. ↵
    Portet F, Cadihac C, Touchon J, Camu W. Cognitive impairment in motor neuron disease with bulbar onset. Amyotroph Lateral Scler Other Motor Neuron Disord . 2001; 2: 23–29.
    OpenUrlCrossRefPubMed
  6. ↵
    Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration. A consensus on clinical diagnostic criteria. Neurology . 1998; 51: 1546–1554.
    OpenUrlAbstract/FREE Full Text
  7. ↵
    Brooks BR, Miller RG, Swash M, et al, for the World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord . 2000; 1: 293–298.
    OpenUrlCrossRefPubMed
  8. ↵
    Chow TW, Miller BL, Hayashi VN, et al. Inheritance of frontotemporal dementia. Arch Neurol . 1999; 56: 817–822.
    OpenUrlCrossRefPubMed
  9. ↵
    Majoor-Krakauer D, Ottman R, Johnson WG, Rowland LP. Familial aggregation of amyotrophic lateral sclerosis, dementia, and Parkinson’s disease: evidence of shared genetic susceptibility. Neurology . 1994; 44: 1872–1877.
    OpenUrlAbstract/FREE Full Text
  10. ↵
    Nakano I. Frontotemporal dementia with motor neuron disease (amyotrophic lateral sclerosis with dementia). Neuropathology . 2000; 20: 68–75.
    OpenUrlCrossRefPubMed

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Abstract
    • Methods.
    • Results.
    • Discussion.
    • References
  • Figures & Data
  • Info & Disclosures
Advertisement

Related Articles

  • No related articles found.

Topics Discussed

  • All Neuromuscular Disease
  • Anterior nerve cell disease
  • Amyotrophic lateral sclerosis
  • Frontotemporal dementia

Alert Me

  • Alert me when eletters are published
Neurology: 99 (6)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • Neurology: Education
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2022 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise